Loading...
Scientist in Physical Sciences and Canada Research Chair – Tier 2 in Contrast Agents and Biosensors
Sunnybrook Research Institute
| The Sunnybrook Research Institute (SRI) is seeking candidates for a Scientist position in the Physical Sciences in contrast agents and biosensors for medical imaging and image-guided therapy. The selected candidate will become member of the Physical Sciences Platform of SRI and may be nominated for Tier 2 Canada Research Chair. Position: Contrast agents and biosensors for medical imaging and image-guided therapy We are seeking a researcher focused on the development of imaging contrast agents or other biosensor approaches that are relevant to the understanding, diagnosis or treatment of disease processes. The research focus can involve imaging modalities such as MRI, PET, optical and ultrasound, and it may relate to multimodal imaging. The approaches employed should provide information related to the visualization and quantification of molecular and cellular events or aspects of the tissue microenvironment. SRI infrastructure is housed within 250,000 square feet of research space that includes a Molecular Targeting and Therapeutics laboratory (for the design, synthesis and bioengineering of agents) as well as a large suite of research and clinical imaging instruments [one 1.5T (GE) and three 3T (GE, Philips, Siemens) research-dedicated MRI systems, a research MRI-PET system (Siemens), a system for MRI-guided focused ultrasound brain treatments (Insightec), a combined X-ray / MRI suite dedicated to research on image-guided interventions, a research CT system (Canon/Toshiba), a 7T small-bore MRI system (Bruker), a vertical 7T NMR system (Bruker), a twin multiphon laser scanning microscope (Olympus), a GE Spinlab polarizer for 13C MRI research, a wide range of ultrasound machines as well as preclinical photoacoustic systems]. This extensive imaging infrastructure is supplemented by a Device Development Lab (DDL; RF electronics and advanced machine shops), a cyclotron, flow cytometry facilities, a whole-mount 3D histopathology laboratory and GMP-grade clean rooms for drug and contrast agent development. How To Apply: Applications should include: 1) a letter of interest of no more than 3 pages. The letter should indicate “sensors position” and briefly describe the applicant’s expertise and their fit with the CRC criteria for a Tier 2 Chair, their proposed research program and its alignment with the foci of the Physical Sciences Platform and the clinical activities in one or more of Sunnybrook’s nine research programs; in addition to the University of Toronto strategic research planand Sunnybrook’s strategic plan; 2) a complete curriculum vitae including professional services, outreach, mentoring / training of highly qualified personnel and other contributions; and 3) a completed self-identification form (see note below). Applicants should email the letter of interest indicating “Biosensors position”, curriculum vitae, self-identification form and the names of three references to CRC@sri.utoronto.ca by February 1, 2021. Notwithstanding this deadline, applications will be considered until the positions are filled. Incomplete applications will not be considered. Selection Process and Criteria: The selection committee, chaired by Dr. David Goertz, will evaluate applicants based on the application packages provided. For more detailed information on the internal selection process and criteria with respect to CRC nominations, please consult SRI’s guidelines for the selection, nomination and administration of CRCs.
|
The applicant must show strong evidence of research and scholarly achievement, and a proven capacity in mentoring and collaboration. The successful applicant will develop an internationally competitive research program and participate in graduate training through an academic appointment in the appropriate department at the University of Toronto (e.g. the Departments of Pharmaceutical Sciences or Medical Biophysics, or the Institute of Biomaterials and Biomedical Engineering). In addition to fostering local, national, and international collaborations, the successful applicant will be expected to collaborate with other SRI Scientists, build complementary translational research capacity, and engage with Sunnybrook Health Sciences Centre Clinicians so as to enable short- and/or long-term clinical translation of their research, ultimately contributing to Sunnybrook’s strategic direction in Personalized and Precise Treatments, with a vision of inventing the future of healthcare. SRI has an outstanding capacity for the development of translational research programs across a range of clinical foci. The applicant’s research program is thus expected to align well with one or more of the nine clinical programsdescribed below.
|
Error
